Thoracic Research and Practice
Scope & Guideline
Pioneering Discoveries in Pulmonary and Respiratory Medicine
Introduction
Aims and Scopes
- Clinical Research in Respiratory Diseases:
The journal emphasizes clinical studies that explore the diagnosis, management, and treatment of various respiratory diseases, including chronic obstructive pulmonary disease (COPD), lung cancer, asthma, and infectious diseases like tuberculosis and COVID-19. - Epidemiological Studies:
It publishes population-based research that assesses the prevalence, risk factors, and outcomes associated with thoracic diseases, providing valuable insights into public health implications. - Innovative Therapeutic Approaches:
The journal highlights research on novel treatment modalities, including pharmacological interventions, surgical outcomes, and rehabilitation strategies for patients with thoracic conditions. - Interdisciplinary Approaches to Thoracic Health:
It encourages interdisciplinary studies that integrate aspects of pulmonology, thoracic surgery, oncology, and psychology to provide a holistic view of patient care. - Quality of Life and Patient-Centered Research:
Research addressing health-related quality of life, patient experiences, and psychosocial factors associated with respiratory diseases is a key focus, reflecting a commitment to patient-centered care.
Trending and Emerging
- Impact of COVID-19 on Respiratory Health:
A significant trend is the exploration of COVID-19's effects on lung health, including long-term consequences and management strategies for patients recovering from the virus. - Telemedicine and Remote Healthcare Solutions:
Research on telemedicine, particularly in the context of respiratory care, is emerging as a vital area of interest, reflecting the shift towards remote patient management and virtual consultations. - Personalized Medicine in Thoracic Disorders:
There is increasing focus on personalized treatment approaches, including the use of biomarkers and individual risk factors to tailor interventions for conditions like lung cancer and asthma. - Environmental and Occupational Lung Diseases:
Emerging studies are addressing the impact of environmental factors, such as air pollution and occupational hazards, on respiratory health, highlighting the need for public health interventions. - Mental Health and Respiratory Conditions:
The intersection of mental health and respiratory diseases is gaining attention, with research exploring how psychological factors influence disease outcomes and patient quality of life.
Declining or Waning
- Traditional Diagnostic Methods:
As research trends towards innovative and advanced diagnostic techniques, traditional methods such as simple radiographic assessments are becoming less emphasized in recent publications. - Basic Science Research:
There appears to be a waning interest in purely basic science studies that do not directly translate to clinical applications, as the journal shifts towards more applied research that impacts patient management. - General Respiratory Conditions:
Specific focus on general respiratory conditions without a clear clinical or epidemiological angle is becoming less frequent, as the journal prioritizes studies with direct implications for treatment and outcomes. - Studies Lacking Multicenter Collaboration:
There is a noticeable decrease in the publication of single-center studies, as the journal increasingly favors multicenter collaborations that enhance the generalizability and impact of research findings. - Historical Reviews and Non-Current Topics:
The journal is moving away from historical reviews and topics that do not align with current clinical challenges, focusing instead on contemporary issues relevant to today's healthcare environment.
Similar Journals
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Pioneering research for a healthier respiratory future.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
BMC Pulmonary Medicine
Connecting researchers and practitioners for impactful insights.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
Zeitschrift fur Pneumologie
Bridging Research and Practice in Respiratory MedicineZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
RESPIROLOGY
Pioneering Research for a Breath of Fresh AirRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Turkish Thoracic Journal
Advancing pulmonary health through innovative research.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
Respiratory Medicine and Research
Pioneering insights in pulmonary care.Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.
Eurasian Journal of Pulmonology
Pioneering open access to vital pulmonology knowledge.The Eurasian Journal of Pulmonology is a premier open access journal dedicated to advancing the field of respiratory medicine and thoracic diseases. Published by KARE PUBL since 1999, the journal serves as an invaluable platform for researchers, clinicians, and students, facilitating the dissemination of innovative research findings and clinical practices. With an emphasis on high-quality and peer-reviewed articles, it aims to foster collaboration and knowledge sharing among professionals in the pulmonology community. Although the journal’s precise impact factor is currently not specified, its commitment to openness and accessibility ensures a broad reach and engagement with vital research, making it a critical resource for those in the academic and medical fields. The journal is based in Istanbul, Turkiye, further enriching its contributions to the Eurasian medical landscape and global health discourse.
BMJ Open Respiratory Research
Driving breakthroughs in respiratory health for a healthier tomorrow.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Tuberculosis and Respiratory Diseases
Exploring the frontiers of respiratory disease management.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
Lung India
Elevating standards in lung disease management.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.